Search results
We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt
Simply Wall St. via Yahoo Finance· 6 days agoSo it might be obvious that you need to consider debt, when you think about how risky any given...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 6 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck Lifts FY24 Outlook After Higher Q1 Earnings, Above Market; Stock Up In Pre-market
RTT News· 6 days agoDrug major Merck & Co., Inc. (MRK), while reporting higher first-quarter earnings, above market estimates, on Thursday raised its fiscal 2024 adjusted earnings and sales view.
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? - Immutep (NASDAQ:IMMP)
Benzinga· 7 days agoImmutep releases preliminary results from TACTI-003 trial showing promising outcomes for first-line...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 5 days agoOn Friday, Wells Fargo adjusted its outlook on shares of pharmaceutical giant Merck & Co., Inc....
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 6 days ago, opens new tab on Thursday raised its annual profit and revenue forecast on the back of strong...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 6 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 6 days agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 7 days agoStrong global underlying demand across Merck’s business, particularly for cancer drug Keytruda and...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 6 days agoZacks Rank & Stocks to Consider Merck currently has a Zacks Rank #3 (Hold). Merck & Co., Inc. Price...